Neovasc Inc.: Neovasc Announces Progress on COSIRA-II Clinical Trial
Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - November 28, 2022) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced an update on the COSIRA-II
Source: finanznachrichten.de